Our Research Publications
Updated November 2023
Pagination
- Previous page
- Page 2
- Next page
Title | Authors | Year Sort ascending | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Do Children With an Allergic Transfusion Reaction Require Premedication or All Blood Products? | Bahabri A, Barty R, Li N, Liu Y, Kovalova T, Chan AKC | 2023 | J Pediatr Hematol Oncol | View Do Children With an Allergic Transfusion Reaction Require Premedication or All Blood Products? | Health care providers | Clinical research |
How do we forecast tomorrow's transfusion? Applying social science approaches to meet tomorrow's transfusion needs: Blood donors and donation | Haw J, Holloway K, Goldman M | 2023 | Transfus Clin Biol | View How do we forecast tomorrow's transfusion? Applying social science approaches to meet tomorrow's transfusion needs: Blood donors and donation | Researchers | Ethical, legal & social implications research |
Taking lessons from nature to improve cell therapy cryopreservation | Acker J, William N, Coatham M | 2023 | Cell Gene Ther Insights | View Taking lessons from nature to improve cell therapy cryopreservation | Researchers | Basic research |
Molecular Screening of Blood Donors for Babesia in Tyrol, Austria | Bloch EM, Siller A, Tonnetti L, Drews SJ, Spencer BR, Hedges D, Mergenthal T, Weber-Schehl M, Astl M, Patel EU, Gaber M, Schennach H | 2023 | Transfus Med Hemother | View Molecular Screening of Blood Donors for Babesia in Tyrol, Austria | Researchers | Clinical research |
Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S | Huynh A, Arnold DM, Michael JV, Clare R, Smith JW, Daka M, Ianosi-Irimie M, McKenzie SE, Kelton JG, Nazy I | 2023 | Blood Adv | View Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S | Researchers | Clinical research |
Donor sex, pre-donation hemoglobin, and manufacturing affect CD71+ cells in red cell concentrates | Li W, William N, Acker JP | 2023 | Transfusion | View Donor sex, pre-donation hemoglobin, and manufacturing affect CD71+ cells in red cell concentrates | Researchers | Basic research |
Lessons learned from the CONCOR-1 trial | Callum J, Bégin P, Jamula E, Liu Y, Kron AT, Auclair MC, Cushing M, Arnold DM | 2023 | Transfus Med | View Lessons learned from the CONCOR-1 trial | Researchers | Clinical research |
An evaluation of the clinical impacts of 7-day platelets | Ning S, Gabarin N, Li N, Liu Y, Lucier K, Barty R, Acker J, Webert KE, Warkentin TE, Arnold DM, Heddle NM | 2023 | Transfusion | View An evaluation of the clinical impacts of 7-day platelets | Researchers | Clinical research |
Cross-Canada Variability in Blood Donor SARS-CoV-2 Seroprevalence by Social Determinants of Health | O’Brien SF, Caffrey N, Yi Q-L, Bolotin S, Janjua NZ, Binka M, Thanh CQ, Stein DR, Lang A, Colquhoun A, Pambrun C, Reedman CN, Drews SJ | 2023 | Microbiol Spectr | View Cross-Canada Variability in Blood Donor SARS-CoV-2 Seroprevalence by Social Determinants of Health | Researchers | Clinical research |
Evaluating variation in perioperative red blood cell transfusion for patients undergoing elective gastrointestinal cancer surgery | Zuckerman J, Coburn N, Callum J, Mahar AL, Lin Y, Turgeon AF, McLeod R, Pearsall E, Martel G, Hallet J | 2023 | Surgery | View Evaluating variation in perioperative red blood cell transfusion for patients undergoing elective gastrointestinal cancer surgery | Researchers | Clinical research |
Alternatives to blood donor deferral of gay, bisexual, and other men who have sex with men: Acceptability of screening the sexual risk behavior of all blood donors | Fisher WA, Kohut T, Woo H, Haw J | 2023 | Transfusion | View Alternatives to blood donor deferral of gay, bisexual, and other men who have sex with men: Acceptability of screening the sexual risk behavior of all blood donors | Blood operators | MSM research |
Prophylaxis use of clotting factor replacement products in people with non-severe haemophilia: A review of the literature | Iorio A, Königs C, Reding MT, Rotellini D, Skinner MW, Mancuso ME, Berntorp E | 2023 | Haemophilia | View Prophylaxis use of clotting factor replacement products in people with non-severe haemophilia: A review of the literature | Health care providers | Clinical research |
Circular of information for the use of human blood components: Plasma Components | Stewart T | 2023 | Blood.ca website | View Circular of information for the use of human blood components: Plasma Components | Health care providers | Benchmarking and standard setting |
Medication use in Canadian blood donors | Goldman M, Miller O, O'Brien SF | 2023 | Vox Sang | View Medication use in Canadian blood donors | Blood operators | Clinical research |
FAQ : plasma traité au solvant-détergent (Octaplasma) | Mack J, Gordon I, Romans R, Webert K, Ning S, Zeller M | 2023 | Blood.ca website | View FAQ : plasma traité au solvant-détergent (Octaplasma) | Health care providers | New or improved product or process |
Humoral and Cellular Response of Transplant Recipients to a Third Dose of mRNA SARS-CoV-2 Vaccine: A Systematic Review and Meta-analysis | Bailey AJM, Maganti HB, Cheng W, Shorr R, Arianne Buchan C, Allan DS | 2023 | Transplantation | View Humoral and Cellular Response of Transplant Recipients to a Third Dose of mRNA SARS-CoV-2 Vaccine: A Systematic Review and Meta-analysis | Researchers | Basic research |
A Survey of Patient Experience in CML: American and Canadian Perspectives | Hillis C, Flynn KE, Goldman EH, Moreira-Lucas TS, Visentini J, Dorman S, Ballinger R, Byrnes HF, De Palma A, Barbier V, Machado L, Atallah E | 2023 | Patient Prefer Adherence | View A Survey of Patient Experience in CML: American and Canadian Perspectives | Researchers | Clinical research |
Prevalence of selected bleeding and thrombotic events in persons with hemophilia versus the general population: A scoping review | Shapiro AD, Hardesty BM, Peyvandi F, Iorio A | 2023 | Res Pract Thromb Haemost | View Prevalence of selected bleeding and thrombotic events in persons with hemophilia versus the general population: A scoping review | Researchers | Clinical research |
Thymic stromal lymphopoietin induces platelet mitophagy and promotes thrombosis in Kawasaki disease | Fu L, MacKeigan DT, Gong Q, Che D, Xu Y, Pi L, Sun C, Yu H, Chen K, Zhou H, Jiang Z, Wang Z, Zhang L, Cerenzia EG, Ni H, Gu X | 2023 | Brit J Haem | View Thymic stromal lymphopoietin induces platelet mitophagy and promotes thrombosis in Kawasaki disease | Researchers | Clinical research |
Transfusion Camp: Successes and challenges in scaling and expanding a transfusion medicine education program | Lin Y, Khandelwal A, Kapitany C, Chargé S | 2023 | Transfus Apher Sci | View Transfusion Camp: Successes and challenges in scaling and expanding a transfusion medicine education program | Health care providers | Education research |
Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques | Stewart T | 2023 | Blood.ca website | View Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques | Health care providers | Benchmarking and standard setting |
FAQ: Solvent detergent (S/D) treated plasma (Octaplasma) | Mack J, Gordon R, Romans R, Webert K, Ning S, Zeller M | 2023 | Blood.ca website | View FAQ: Solvent detergent (S/D) treated plasma (Octaplasma) | Health care providers | New or improved product or process |
Auditing a recently implemented massive hemorrhage protocol: feasibility of assessing pre-specified metrics and compliance | Leis M, Clarfield L, Lin Y, Gupta A, Da Luz L | 2023 | CJEM | View Auditing a recently implemented massive hemorrhage protocol: feasibility of assessing pre-specified metrics and compliance | Health care providers | Benchmarking and standard setting |
KEL1 negative red cell transfusions for females of current or future child-bearing potential: A clinical impact and feasibility study | Ning S, Morin PA, Elahie A, Li N, Liu Y, Barty R, Clarke G, Zeller M, Heddle NM | 2023 | Transfusion | View KEL1 negative red cell transfusions for females of current or future child-bearing potential: A clinical impact and feasibility study | Health care providers | Clinical research |
Les fournisseurs de sang canadiens : un rôle croissant dans la surveillance de la santé publique? | O’Brien SF, Drews SJ, Lewin A, Osiowy C, Drebot MA, Renaud C | 2022 | Relevé des maladies transmissibles au Canada | View Les fournisseurs de sang canadiens : un rôle croissant dans la surveillance de la santé publique? | Health care providers | New or improved product or process |
Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia | Kaur MN, Arnold DM, Heddle NM, Cook RJ, Hsia C, Blostein M, Jamula E, Sholzberg M, Lin Y, Kassis J, Larratt L, Tinmouth A, Carruthers J, Li N, Liu Y, Xie F | 2022 | Blood Adv | View Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia | Health care providers | Clinical research |
Loss of repeat convalescent plasma donors due to waning anti-SARS-CoV-2 plaque reduction neutralization test titers (April-December 2020) | Drews S, Devine D, McManus J, Mendoza E, Manguiat K, Girardin R, Dupuis A, McDonough K, Lin J, Evans D, Pambrun C, Drebot M, Wood H | 2022 | Transfus Med Rev | View Loss of repeat convalescent plasma donors due to waning anti-SARS-CoV-2 plaque reduction neutralization test titers (April-December 2020) | Blood operators | New or improved product or process |
Plaquettes extraites de la couche leucoplaquettaire à teneur réduite en agents pathogènes | Blais-Normandin I, Tordon B, Anani W | 2022 | Blood.ca website | View Plaquettes extraites de la couche leucoplaquettaire à teneur réduite en agents pathogènes | Health care providers | Benchmarking and standard setting |
Methods to Evaluate the Potential Clinical Significance of Antibodies to Red Blood Cells | Boligan KF, Sandhu G, Branch DR | 2022 | Curr Protoc | View Methods to Evaluate the Potential Clinical Significance of Antibodies to Red Blood Cells | Researchers | Benchmarking and standard setting |
Management of immune‐mediated thrombocytopenia | Gabe C, Arnold D, Smith J, T W | 2022 | Rossi's Principles of Transfusion Medicine | View Management of immune‐mediated thrombocytopenia | Health care providers | Benchmarking and standard setting |
Why We Swab: A library of stories in stem cell donation | Jagelaviciute G, Kum E, Li EW, Rosenfeld A, Williams K, Kandel R, DeGurse N, Park B, Okonofua S, Sano L, Gerofsky M, Sharp A, Hatkar R, Thyagu S, Fingrut WB | 2022 | Transfusion | View Why We Swab: A library of stories in stem cell donation | Health care providers | Ethical, legal & social implications research |
Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses | Lin Y-CJ, Evans DH, Robbins NF, Orjuela G, Hu Q, Samson R, Abe KT, Rathod B, Colwill K, Gingras A-C, Tuite A, Yi Q-L, O’Brien SF, Drews SJ | 2022 | Microbiol Spectr | View Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses | Health care providers | Benchmarking and standard setting |
Déclaration du CCN concernant le génotypage du RHD chez les patientes enceintes | Pavenski K, Khandelwal A, Clarke G, Lane D | 2022 | National Advisory Committee on Blood and Blood Products | View Déclaration du CCN concernant le génotypage du RHD chez les patientes enceintes | Health care providers | Benchmarking and standard setting |
A mixed methods investigation of the relationship between blood donor policy, interest in donation, and willingness to donate among gay, bisexual, and other men who have sex with men in Ontario, Canada | Armstrong JP, Brennan DJ, Collict D, Kesler M, Bekele T, Souleymanov R, Grace D, Lachowsky NJ, Hart TA, Adam BD | 2022 | BMC Public Health | View A mixed methods investigation of the relationship between blood donor policy, interest in donation, and willingness to donate among gay, bisexual, and other men who have sex with men in Ontario, Canada | Researchers | MSM research |
Staff perspectives on barriers and enablers to implementing alternative source plasma eligibility criteria for gay, bisexual, and other men who have sex with men | Castillo G, Vesnaver E, Gibson E, Butler-Foster T, Goldman M, Hill NE, Rosser A, Lapierre D, Rubini KA, MacDonagh R, Miguel G, Palumbo A, MacPherson P, Randall T, Osbourne-Sorrell W, O'Brien SF, Bridel W, Otis J, Greaves M, Al-Bakri TB, Reid M, Labrecque M, Germain M, Orvis S, Clapperton AT, Devine D, Presseau J | 2022 | Transfusion | View Staff perspectives on barriers and enablers to implementing alternative source plasma eligibility criteria for gay, bisexual, and other men who have sex with men | Blood operators | MSM research |
A Prospective Observational Cohort Comparison of SARS-CoV-2 Seroprevalence Between Paramedics and Matched Blood Donors in Canada During the COVID-19 Pandemic | Grunau B, O’Brien SF, Kirkham TL, Helmer J, Demers PA, Asamoah-Boaheng M, Drews SJ, Karim ME, Srigley JA, Sediqi S, O’Neill D, Drennan IR, Goldfarb DM | 2022 | Ann Emerg Med | View A Prospective Observational Cohort Comparison of SARS-CoV-2 Seroprevalence Between Paramedics and Matched Blood Donors in Canada During the COVID-19 Pandemic | Researchers | Clinical research |
FAQ: Information for health professionals on pathogen-reduced platelets | Ning S, Tordon B, Zeller M, Anani W | 2022 | Blood.ca website | View FAQ: Information for health professionals on pathogen-reduced platelets | Health care providers | New or improved product or process |
Whole blood donor return rates after deferral for tattooing or body piercing—Survey across blood donation services: The BEST collaborative study | Quee F, O'Brien SF, Prinsze F, Steele WR, Grégoire Y, Cutajar A, Wendel S, Compernolle V, Goldman M, van den Hurk K, Biomedical Excellence for Safer Transfusion Collaborative | 2022 | Vox Sang | View Whole blood donor return rates after deferral for tattooing or body piercing—Survey across blood donation services: The BEST collaborative study | Blood operators | Benchmarking and standard setting |
Sommaire des réactions transfusionnelles indésirables | Yan M | 2022 | Blood.ca website | View Sommaire des réactions transfusionnelles indésirables | Blood operators | Benchmarking and standard setting |
T cell-mediated autoimmunity in immune thrombocytopenia | Vrbensky JR, Nazy I, Clare R, Larché M, Arnold DM | 2022 | Eur J Haematol | View T cell-mediated autoimmunity in immune thrombocytopenia | Researchers | Clinical research |
Implementation of a blood bank generated tube for second blood group determination: Challenges, yield, and cost | Obaidallah N, Downie H, Colavecchia C, Callum J, Lin Y | 2022 | Transfusion | View Implementation of a blood bank generated tube for second blood group determination: Challenges, yield, and cost | Health care providers | New or improved product or process |
Impact of cardiopulmonary bypass duration on efficacy of fibrinogen replacement with cryoprecipitate compared with fibrinogen concentrate: a <em>post hoc</em> analysis of the Fibrinogen Replenishment in Surgery (FIBRES) randomised controlled trial | Bartoszko J, Martinez-Perez S, Callum J, Karkouti K, Farouh ME, Scales DC, Heddle NM, Crowther M, Rao V, Hucke H-P, Carroll J, Grewal D, Brar S, Brussières J, Grocott H, Harle C, Pavenski K, Rochon A, Saha T, Shepherd L, Syed S, Tran D, Wong D, Zeller M | 2022 | Br J Anaesth | View Impact of cardiopulmonary bypass duration on efficacy of fibrinogen replacement with cryoprecipitate compared with fibrinogen concentrate: a <em>post hoc</em> analysis of the Fibrinogen Replenishment in Surgery (FIBRES) randomised controlled trial | Researchers | Clinical research |
Evaluation of the performance of multiple immunoassay diagnostic platforms on the National Microbiology Laboratory SARS-CoV-2 National Serology Panel | Dibernardo A, Toledo NP, Robinson A, Osiowy C, Giles E, Day J, Lindsay LR, Drebot MA, Booth TF, Pidduck T, Baily A, Charlton CL, Tipples G, Kanji JN, Brochu G, Lang A, Therrien C, Bélanger-Collard M, Beaulac S-N, Gilfix BM, Boivin G, Hamelin M-È, Carbonneau J, Lévesque S, Martin P, Finzi A, Gendron-Lepage G, Goyette G, Benlarbi M, Gasser R, Fortin C, Martel-Lafferrière V, Lavoie M, Guérin R, Haraoui L-P, Renaud C, Jenkins C, O'Brien SF, Drews SJ, Conrod V, Tran V, Awrey B, Scheuermann R, DuPuis A, Payne A, Warszycki C, Girardin R, Lee W, Zahariadis G, Jiao L, Needle R, Cordenbach J, Zaharatos J, Taylor K, Teltscher M, Miller M, Elsherif M, Robertson P, Robinson JL | 2022 | J Assoc Med Microbiol Infect Dis Can | View Evaluation of the performance of multiple immunoassay diagnostic platforms on the National Microbiology Laboratory SARS-CoV-2 National Serology Panel | Researchers | Benchmarking and standard setting |
The bending rigidity of the red blood cell cytoplasmic membrane | Himbert S, D’Alessandro A, Qadri SM, Majcher MJ, Hoare T, Sheffield WP, Nagao M, Nagle JF, Rheinstädter MC | 2022 | PLoS One | View The bending rigidity of the red blood cell cytoplasmic membrane | Researchers | Basic research |
A Primer on Biostatistics | Shih AW, Li N, Montemayor C, Heddle NM | 2022 | Practical Transfusion Medicine | View A Primer on Biostatistics | Health care providers | Benchmarking and standard setting |
Pathogen-reduced buffy coat platelets | Blais-Normandin I, Tordon B, Anani W | 2022 | Blood.ca website | View Pathogen-reduced buffy coat platelets | Health care providers | Benchmarking and standard setting |
Early and out-of-hospital use of COVID-19 convalescent plasma: An international assessment of utilization and feasibility | Al-Riyami AZ, Estcourt L, Rahimi-Levene N, Bloch EM, Goel R, Tiberghien P, Thibert J-B, Bruun MT, Devine DV, Gammon RR, Wendel S, Toungouz Nevessignsky M, Grubovic Rastvorceva RM, Oreh A, Romon I, van den Berg K, Kitazawa J, Patidar G, So-Osman C, Wood EM, the ISBT COVID-19 Convalescent Plasma Working Group | 2022 | Vox Sang | View Early and out-of-hospital use of COVID-19 convalescent plasma: An international assessment of utilization and feasibility | Health care providers | Clinical research |
von Willebrand factor propeptide variants lead to impaired storage and ER retention in patient-derived endothelial colony-forming cells | Bowman M, Casey L, Selvam SN, Lima PDA, Rawley O, Hinds M, Tuttle A, Grabell J, Iorio A, Walker I, Lillicrap D, James P | 2022 | J Thromb Haemost | View von Willebrand factor propeptide variants lead to impaired storage and ER retention in patient-derived endothelial colony-forming cells | Researchers | Basic research |
Vaccine-induced immune thrombotic thrombocytopenia: Updates in pathobiology and diagnosis | Jevtic SD, Arnold DM, Modi D, Ivetic N, Bissola AL, Nazy I | 2022 | Front Cardiovasc Med | View Vaccine-induced immune thrombotic thrombocytopenia: Updates in pathobiology and diagnosis | Health care providers | Clinical research |
Accuracy of International Classification of Diseases, 10th Revision Codes for Identifying Sepsis: A Systematic Review and Meta-Analysis | Liu B, Hadzi-Tosev M, Liu Y, Lucier KJ, Garg A, Li S, Heddle NM, Rochwerg B, Ning S | 2022 | Crit Care Explor | View Accuracy of International Classification of Diseases, 10th Revision Codes for Identifying Sepsis: A Systematic Review and Meta-Analysis | Health care providers | Clinical research |